Both in Pharmaceuticals
Zenas BioPharma vs Braveheart Bio
Over the past year ZBIO returned −8.8% and BRVE returned −19.7%; their daily moves had a correlation of 0.11.
ZBIO −8.8% BRVE −19.7%Growth of $1, one year, split-adjusted
| Metric | ZBIO | BRVE |
|---|---|---|
| Price | $28.38 | $21.39 |
| Market cap | $1.85B | $1.93B |
| Today | +2.75% | +1.66% |
| 1 month | +2.0% | +0.2% |
| 6 months | +36.7% | — |
| Year to date | −21.8% | — |
| 1 year | −9.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −11145.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 1,849.7× | — |
| Net cash | $346.1M | — |
| Dividend yield | — | — |
| Volatility (60d) | 55.9% | — |
| Short % of float | 40.2% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).